Xia Baolong, Secretary of Zhejiang Provincialβ♣ Party Committee, and his party visit≈∞•☆ed Wanbangde Group for investiga©tion and investigation
- Categories:Leadership care
- Author:
- Origin:
- Time of issue:2022-03-14
- Views:0
(Summary description)On June 26, Xia Baolong♦₩, Secretary of Zhejiang×✔ Provincial Party Committee, visited Wan↑✘↕bangde Group for inspection. Zhao Yide, Me∏∑↓¥mber of the Standing Committee ∞↔♣∏of the Provincial Party Committee and Secre& tary-General of the Provincial Party Commit'δλΩtee, Zhou Xianmiao, Secretary of th©×Ω÷e Wenling Municipal Party Committee,ε÷∞ and Zhao Shouming, ≠↓←Chairman of Wanbangde Pharmaceutical Group, acco✔®∞mpanied the whole process.
Xia Baolong, Secretary of Zhejian★π∞g Provincial Party Comm✘₩★≠ittee, and his party visit★¶ed Wanbangde Group for investigation and inves<ε≈tigation
(Summary description)On June 26, Xia Baolong,↓✘↕ Secretary of Zhejiang §←Provincial Party Com≠♥★±mittee, visited Wanbang©γ™de Group for inspection. Zhao Yide, Membe♣σ₩≤r of the Standing Committee of the P≥ε☆<rovincial Party Committee and Secretary-Ge★ neral of the Provincial Pa rty Committee, Zhou Xi★¥↔☆anmiao, Secretary of the Wenling Muni↓σ±cipal Party Committee, and Zhao Shouming, Cha>αirman of Wanbangde Pharmaceutical Group, accomp★←®÷anied the whole process.
- Categories:Leadership care
- Author:
- Origin:
- Time of issue:2022-03-14
- Views:0
On June 26, Xia Baolong, Secretary of Zhejia★↓>ng Provincial Party Cβ←♣ommittee, visited Wanbangd♠≠¶αe Group for inspection. Zhao Yide, Member of the €£Standing Committee of the Provincial Par§δ÷>ty Committee and Secretary-General of the Pr♠♦∏ovincial Party Committee, Zhou Xδ↑£™ianmiao, Secretary of the WenlinΩ₹•g Municipal Party Committee, and Zhao Shouming, C γhairman of Wanbangde Pharmaceutical Group, accoγ>♣mpanied the whole process.
Secretary Xia Baolong and his party first vis£™¥ited the preparation bui♦lding of Wanbangde P→£λ§harmaceutical Group, and λ∏∏≥successively visited the three pr≤↕♦≈oduction departments of the large-volume i αnjection flushing liquid workshop, the small-vλ∞olume injection eye drops≈<♣ workshop, and the pill-dr←£₹opping workshop. project”÷∏βδ to conduct field research. In addition, Secreta£₩ry Xia Baolong also paid attention to±¥↓× the production line of ginkgo leaf dropping $✘pills, and expressed his high appreci ♣λation for Wanbangde Pharmaceut→£✔Ωical Group's huge investment in in$ troducing advanced eq₽×uipment to improve production efficiency. ↔≥¶Secretary Xia Baolong pointed out that'↕$ Ginkgo biloba dripping pills are widely us∞>≠πed, and we must do a good →☆job in the research and developmΩ&ent of series products. At the ♥β™same time, it is emphasi±←zed that Wanbangde Pharmaceutical Gr☆>©oup should give full play to i©ts advantages, increase resea'∑rch and development efforts, improve it♦σ≥s marketing network and expand its∑∏ production scale.
Later, Secretary Xia Bao↑σ♠long listened to Chairman Zhao Shou÷₹♣≠ming's report on¶™↔ the company's prod≥₽uction and operation, technol₩"ogical innovation, and product sales. λεSecretary Xia Baolong pointed out that Wanbangde♦✔ Pharmaceutical Group should develop comprehenβ±€sively in the future and take a dive™↕¥rsified development pa↑σαth of medicines, medical eq☆÷> uipment and medical care. Chairman Zhao Shoum δ€ing said sincerely that Wanbangα±₽≈de Pharmaceutical Group ↓≥will definitely live up to ∞☆→the ardent hopes of the leaders and make the c×♦ompany's products more ref≈™ined, specialized and stronger.
Secretary Xia Baolong≠↕ (the first from theβ₽ right) visited the drippin←≠&∞g production line
Scan the QR code to read on your phone
The public service platform project f£↓§or the industrialization of innovative achievem☆™ents in the field of medical equipment±€ settled in the China-Africa Inter<¥∑☆national Pharmaceutic≥ ¥£al Industry Cooperation Par₽λ€₹k
The 2017 National Medical Device Supervision∑♦α₹ and Management Work Conf¥₽erence opened in Beijing
45% of medical device registration items in Z•≥hejiang Food and Drug Administratiσ>'on implement the new "Internet +" approvalφ©∑ model
